US EditionPublished • loading... • Updated
New CMS Demo Aims to Increase Access to GLP-1s Under Medicaid and Part D
Summary by MedPage Today
2 Articles
2 Articles
MedPage TodayReposted by 
Anti-Aging, Acupuncture and Health News
Anti-Aging, Acupuncture and Health NewsNew CMS Demo Aims to Increase Access to GLP-1s Under Medicaid and Part D
(MedPage Today) -- The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it's unclear how popular or effective it will...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
